Efavirenz + Emtricitabine + Tenofovir
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Efavirenz
efavirenz - Emtricitabine
emtricitabine - Tenofovir
tenofovir
Brands with this exact combination
| Brand | Composition & strength | Manufacturer |
|---|---|---|
| TREMIXCLARMX |
| Sandoz, S.A. de C.V. |
| ATRIPLA 600 mg/200 mg/245 mg, comprimé pelliculéFR |
| GILEAD SCIENCES IRELAND UC (IRLANDE) |
| EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL ARROW 600 mg/200 mg/245 mg, comprimé pelliculéFR |
| ARROW GENERIQUES |
| EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL BIOGARAN 600 mg/200 mg/245 mg, comprimé pelliculéFR |
| BIOGARAN |
| EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL EG 600 mg/200 mg/245 mg, comprimé pelliculéFR |
| EG LABO - LABORATOIRES EUROGENERICS |
| EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA 600 mg/200 mg/245 mg, comprimé pelliculéFR |
| KRKA (SLOVENIE) |
| EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL MYLAN 600 mg/200 mg/245 mg, comprimé pelliculéFR |
| MYLAN PHARMACEUTICALS (IRLANDE) |
| EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL SANDOZ 600 mg/200 mg/245 mg, comprimé pelliculéFR |
| SANDOZ |
| EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL TEVA 600 mg/200 mg/245 mg, comprimé pelliculéFR |
| TEVA SANTE |
| EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL ZENTIVA 600 mg/200 mg/245 mg, comprimé pelliculéFR |
| ZENTIVA (REPUBLIQUE TCHEQUE) |
Same combination in other markets
Cross-market comparison is not available for this grouped name.
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.